All participants | |
---|---|
n | 174 |
Male (n, %) | 122 (68.5%) |
Age (years) | 53.0 ± 10.6 |
BMI (kg/m2) | 25.69 ± 3.29 |
History of DM | 64 (36.8%) |
DM course (years) | |
0–1 | 34 (14.7%) |
1–10 | 74 (31.9%) |
10–20 | 49 (21.1%) |
≥ 20 | 17 (7.3%) |
Hypertension | 70 (40.2%) |
Smoking | 65 (37.4%) |
Drinking | 53 (30.5%) |
Usage of insulin | 54 (31.0%) |
HbA1c (%) | 9.1 (7.6, 10.9) |
FBG (mmol/L) | 6.49 (5.65, 7.85) |
FCP (ng/mL) | 1.66 (1.12, 2.47) |
TC (mmol/L) | 4.72 (4.06, 5.55) |
TG (mmol/L) | 1.43 (0.98, 2.19) |
HDL-C (mmol/L) | 1.05 (0.90, 1.18) |
LDL-C (mmol/L) | 3.09 (2.62, 3.73) |
ApoA1 (mmol/L) | 1.23 (1.12, 1.37) |
ApoB (mmol/L) | 0.80 (0.70, 0.98) |
Total protein (g/L) | 68.58 ± 5.80 |
Albumin (g/L) | 41.59 ± 2.87 |
25OHD (ng/mL) | 18.37 (13.36, 23.85) |
OC (ng/mL) | 12.00 (9.64, 15.61) |
β-CTX (ng/mL) | 0.35 (0.24, 0.52) |
P1NP (ng/mL) | 37.33 (29.25, 50.73) |
PTH (pg/mL) | 35.52 (25.00, 46.57) |
Modified HOMA-β | 451.30 (285.19, 633.52) |